Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer.

Salhab M, Singh-Ranger G, Mokbel R, Jouhra F, Jiang WG, Mokbel K.

J Surg Oncol. 2007 Oct 1;96(5):424-8.

PMID:
17657731
2.

The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.

Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K.

Breast Cancer Res Treat. 2006 Sep;99(2):155-62. Epub 2006 Mar 16.

PMID:
16541304
3.

Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.

Irahara N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.

Cancer Lett. 2006 Nov 8;243(1):23-31. Epub 2006 Mar 23.

PMID:
16556483
4.

The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.

Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K.

Anticancer Res. 2006 Nov-Dec;26(6C):4985-90.

5.
6.
7.

Expression of COX-2 and steroid converting enzymes in breast cancer.

Gunnarsson C, Jansson A, Holmlund B, Ferraud L, Nordenskjöld B, Rutqvist LE, Skoog L, Stål O.

Oncol Rep. 2006 Aug;16(2):219-24.

PMID:
16820896
8.

Real-time reverse transcription PCR assay of CYP19 expression: application to a well-defined series of post-menopausal breast carcinomas.

Girault I, Lerebours F, Tozlu S, Spyratos F, Tubiana-Hulin M, Lidereau R, Bièche I.

J Steroid Biochem Mol Biol. 2002 Nov;82(4-5):323-32.

PMID:
12589939
9.

Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer.

McCarthy K, Bustin SA, Ogunkolade B, Khalaf S, Laban CA, McVittie CJ, Carpenter R, Jenkins PJ.

Eur J Surg Oncol. 2006 Sep;32(7):707-9. Epub 2006 May 2.

PMID:
16650963
10.

[mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].

Zheng HY, Chen Q, Ye YB, Huang WW.

Zhonghua Yi Xue Za Zhi. 2008 Aug 19;88(32):2267-70. Chinese.

PMID:
19087676
11.

Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.

Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H.

Cancer Res. 2007 Apr 15;67(8):3945-54.

12.

In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.

Licznerska BE, Wegman PP, Nordenskjöld B, Wingren S.

Breast Cancer Res Treat. 2008 Nov;112(1):15-23. Epub 2007 Nov 20.

PMID:
18030614
13.

Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer.

Singh-Ranger G, Kirkpatrick KL, Clark GM, Mokbel K.

Curr Med Res Opin. 2003;19(2):131-4.

PMID:
12740157
14.

Possible involvement of aromatase overexpression induced by cyclo-oxygenase-2 in the pathogenesis of idiopathic gynecomastia.

Irahara N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S, Harada N.

Endocr Res. 2005;31(3):219-27.

PMID:
16392624
15.

Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.

Singer CF, Fink-Retter A, Gschwantler-Kaulich D, Thalhammer T, Hudelist G, Mueller R, Czerwenka K, Kubista E.

Endocr Relat Cancer. 2006 Dec;13(4):1101-7.

16.

Paracrine-stimulated gene expression profile favors estradiol production in breast tumors.

Amin SA, Huang CC, Reierstad S, Lin Z, Arbieva Z, Wiley E, Saborian H, Haynes B, Cotterill H, Dowsett M, Bulun SE.

Mol Cell Endocrinol. 2006 Jul 11;253(1-2):44-55. Epub 2006 Jun 2.

PMID:
16735089
17.

[Expression of the cyclooxygenase-2 gene in human breast carcinoma].

Zhao XQ, Pang D, Xue YW.

Zhonghua Wai Ke Za Zhi. 2003 Jun;41(6):427-9. Chinese.

PMID:
12895350
18.

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.

Lykkesfeldt AE, Henriksen KL, Rasmussen BB, Sasano H, Evans DB, Møller S, Ejlertsen B, Mouridsen HT.

BMC Cancer. 2009 Jun 16;9:185. doi: 10.1186/1471-2407-9-185.

19.

Aromatase and COX in breast cancer: enzyme inhibitors and beyond.

Brueggemeier RW, Su B, Sugimoto Y, Díaz-Cruz ES, Davis DD.

J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):16-23. Epub 2007 May 25.

20.

Down-regulation of intratumoral aromatase messenger RNA levels by docetaxel in human breast cancers.

Miyoshi Y, Kim SJ, Akazawa K, Kamigaki S, Ueda S, Yanagisawa T, Inoue T, Taguchi T, Tamaki Y, Noguchi S.

Clin Cancer Res. 2004 Dec 15;10(24):8163-9.

Supplemental Content

Support Center